Opaleye Management Inc. has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission on March 28, 2024, indicating a significant ownership stake in iBio Inc. The filing reveals that Opaleye Management holds 650,000 shares of iBio Inc.'s common stock, which represents 7.63% of the company's total shares issued and outstanding as of April 1, 2024. This ownership level is based on 8,515,226 shares of common stock outstanding, as reported by iBio Inc. in its registration statement. The shares are reported to be held with shared voting and dispositive power, and the filing asserts that the acquisition of these shares is not for the purpose of changing or influencing the control of iBio Inc.

Opaleye Management Inc. has filed an amended Schedule 13G/A with the United States Securities and Exchange Commission on March 28, 2024, indicating a significant ownership stake in iBio Inc. The filing reveals that Opaleye Management holds 650,000 shares of iBio Inc.'s common stock, which represents 7.63% of the company's total shares issued and outstanding as of April 1, 2024. This ownership level is based on 8,515,226 shares of common stock outstanding, as reported by iBio Inc. in its registration statement. The shares are reported to be held with shared voting and dispositive power, and the filing asserts that the acquisition of these shares is not for the purpose of changing or influencing the control of iBio Inc.